您当前的位置：
首页 >
文章列表页 >
Experience in managing primary immune thrombocytopenia with high-dose Sangye (Folium Mori)
Theoretical Exploration | 更新时间：2024-11-29
|

    • Experience in managing primary immune thrombocytopenia with high-dose Sangye (Folium Mori)

    • “最新研究发现，桑叶可用于治疗原发免疫性血小板减少症，与ITP病机高度契合，为疾病治疗提供新方案。”
    • Modern Chinese Clinical Medicine   Vol. 31, Issue 6, Pages: 104-108(2024)

    • DOI：10.3969/j.issn.2095-6606.2024.06.022    

      CLC： R255.7;R259

    • Published：30 November 2024，

      Received：16 October 2023，

    移动端阅览

  • LI SHUANG, YV HANG, PAN YANJUN, et al. Experience in managing primary immune thrombocytopenia with high-dose Sangye (Folium Mori). [J]. Modern chinese clinical medicine, 2024, 31(6): 104-108. DOI： 10.3969/j.issn.2095-6606.2024.06.022.

  •  
  •  

0

Views

36

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0